10x Insights
Loading account…
Companies / Health Care / Cypherpunk Technologies Inc.
CYPH

Cypherpunk Technologies Inc.

Health CarePharmaceutical Preparations
Ticker CYPHCAMBRIDGE, MAFiscal year ends DecemberBook value per share $0.79Diluted shares 176.3M

Cypherpunk Technologies Inc. (Nasdaq: CYPH) is a privacy technology company with a digital asset treasury strategy focused on Zcash, alongside cancer drug development through its wholly owned subsidiary, Leap Therapeutics. Its privacy business aims to identify, develop, invest in, and potentially acquire or build… From the company’s description.

In fiscal 2025, Cypherpunk Technologies Inc. reported net income of $4.82M. Operations used $43.90M in cash.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
—
0.00%FY2025
$4.82MFY2025
+107.1% year over year
Last 12 mo $-0.88M
4.55%FY2025
+197.3 percentage points
Last 12 mo -0.63%
Cash & financing
$-43.90MFY2025
+27.2% year over year
Last 12 mo $-21.06M
$-43.90MFY2025
+27.2% year over year
Last 12 mo $-21.06M
—
70.7MFY2025
+88.2% year over year
Last 12 mo 176.3M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What Cypherpunk Technologies Inc. does

In the company’s own words

Cypherpunk Technologies Inc. (Nasdaq: CYPH) is a privacy technology company with a digital asset treasury strategy focused on Zcash, alongside cancer drug development through its wholly owned subsidiary, Leap Therapeutics. Its privacy business aims to identify, develop, invest in, and potentially acquire or build privacy-enhancing technologies, with an initial focus on the Zcash ecosystem and ZEC, the network’s digital asset. Zcash supports both transparent and shielded transactions, using zero-knowledge cryptography to enable transaction validation without publicly revealing transaction details. As of March 11, 2026, Cypherpunk held 294,743.10 ZEC. Leap develops biomarker-targeted antibody therapies, led by sirexatamab (DKN-01), an investigational antibody targeting DKK1 that has completed a Phase 2 study in colorectal cancer. Leap also has FL-501, a preclinical antibody program targeting GDF-15 for cachexia-related and other indications. The company changed its name from Leap Therapeutics, Inc. in November 2025, retaining biotechnology operations under the Leap subsidiary.

Company details
Sector
Health Care
Industry (SIC)
Pharmaceutical Preparations
Headquarters
CAMBRIDGE, MA
Fiscal year end
December
CIK
1509745
SIC
2834

Financial performance, year by year

Fiscal 2017–2025 · USD
$-90.04M$-64.17M$-38.30M$-12.43M$13.45M201720182019202020212022202320242025Last 12 moLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns Cypherpunk Technologies Inc. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

10
funds hold it
0 of 35
superinvestors hold it
$2.94M
held by funds, at market
4.1%
of shares held by funds

Largest fund holders · Cypherpunk Technologies Inc.’s weight in each

VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
VANGUARD EXTENDED MARKET INDEX FUND
VXF · VANGUARD INDEX FUNDS
0.00%of fund net assets
Fidelity Extended Market Index Fund
FSMAX · Fidelity Concord Street Trust
—of fund net assets
Fidelity Total Market Index Fund
FSKAX · Fidelity Concord Street Trust
—of fund net assets
Fidelity Series Total Market Index Fund
FCFMX · Fidelity Concord Street Trust
—of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do Cypherpunk Technologies Inc. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of Cypherpunk Technologies Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in Cypherpunk Technologies Inc.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.